Association between APOE ε4 Allele and Vascular Dementia: The Cache County Study

被引:61
作者
Chuang, Yi-Fang [1 ]
Hayden, Kathleen M. [2 ]
Norton, Maria C. [5 ]
Tschanz, Joann [5 ]
Breitner, John C. S. [3 ,4 ]
Welsh-Bohmer, Kathleen A. [2 ]
Zandi, Peter P. [1 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
[2] Duke Univ, Med Ctr, Durham, NC USA
[3] VA Puget Sound Hlth Care Syst, Seattle, WA USA
[4] Univ Washington, Seattle, WA 98195 USA
[5] Utah State Univ, Logan, UT 84322 USA
关键词
APOE; Vascular dementia; APOLIPOPROTEIN-E POLYMORPHISM; ALZHEIMERS-DISEASE; POPULATION; CHOLESTEROL; FREQUENCY; QUESTIONNAIRE; RELIABILITY; PREVALENCE; GENOTYPE; VALIDITY;
D O I
10.1159/000285166
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background: The APOE epsilon 4 allele is an established risk factor for Alzheimer's disease, but reports of its association with vascular dementia (VaD) have been inconsistent. We examined the relationship between APOE epsilon 4 allele and the risk of incident VaD in a large, population-based cohort of elderly adults with up to 10 years of follow-up between 1995 and 2005. Methods: A total of 3,424 elderly men and women free of dementia were genotyped at the baseline assessment. Incident VaD was identified through standardized procedures administered at 3 follow-up assessments. Cox proportional hazards models were used to evaluate the risk of VaD associated with APOE epsilon 4. Results: The adjusted hazard ratio was 1.6 for the participants with 1 APOE epsilon 4 allele (95% CI: 0.9-2.7; p = 0.083) and 4.4 for those with 2 APOE epsilon 4 alleles ( 95% CI: 1.6-12.5; p = 0.005). The increased risk did not appear to be mediated by vascular risk factors. Conclusions: The APOE epsilon 4 allele is associated with an increased risk of VaD in a dose-dependent fashion and accounts for almost 20% of VaD in the population. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:248 / 253
页数:6
相关论文
共 40 条
[31]  
SILVERMAN JM, 1986, AM J PSYCHIAT, V143, P1279
[32]   Apolipoprotein E epsilon 4 and the risk of dementia with stroke - A population-based investigation [J].
Slooter, AJC ;
Tang, MX ;
vanDuijn, CM ;
Stern, Y ;
Ott, A ;
Bell, K ;
Breteler, MMB ;
Van Broeckhoven, C ;
Tatemichi, TK ;
Tycko, B ;
Hofman, A ;
Mayeux, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (10) :818-821
[33]   Coronary artery disease, hypertension, ApoE, and cholesterol: A link to Alzheimer's disease? [J].
Sparks, DL .
CEREBROVASCULAR PATHOLOGY IN ALZHEIMER'S DISEASE, 1997, 826 :128-146
[34]  
STENGARD JH, 1995, ACTA NEUROL SCAND, V92, P297
[35]  
Tatemichi Thomas K., 1994, P123
[36]  
TENG EL, 1987, J CLIN PSYCHIAT, V48, P314
[37]  
Tschanz JT, 2002, NEUROPSY NEUROPSY BE, V15, P28
[38]   Dementia diagnoses from clinical and neuropsychological data compared - The Cache County study [J].
Tschanz, JT ;
Welsh-Bohmer, KA ;
Skoog, I ;
West, N ;
Norton, MC ;
Wyse, BW ;
Nickles, R ;
Breitner, JCS .
NEUROLOGY, 2000, 54 (06) :1290-1296
[39]   Genetic Aspects of Alzheimer Disease [J].
Williamson, Jennifer ;
Goldman, Jill ;
Marder, Karen S. .
NEUROLOGIST, 2009, 15 (02) :80-86
[40]  
Yang JD, 2001, INT J MOL MED, V7, P217